ORCHARD THERAPEUTICS PLC-ADR (ORTX)
US68570P2002 - ADR
| MRQ (2023-9-30) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 23.50M | 68.40M | 55.90M | 55.10M | 19.10M | |||
| Marketable Securities | 101.90M | 75.30M | 164.20M | 136.80M | 305.90M | |||
| Receivables | 17.00M | 17.30M | 36.70M | 21.00M | 16.40M | |||
| Inventories | 6.60M | 3.40M | 2.00M | 700.00K | N/A | |||
| Other Current Assets | 4.90M | 3.70M | 16.50M | 9.90M | 8.50M | |||
| Total Current Assets | 153.90M | 168.10M | 275.30M | 223.50M | 349.90M | |||
| Non-Current Assets | ||||||||
| PPE Net | 27.10M | 30.90M | 29.10M | 34.60M | 27.00M | |||
| Intangibles | 3.30M | 3.60M | 5.60M | N/A | N/A | |||
| Other Non-Current Assets | 14.50M | 16.30M | 12.50M | 22.80M | 8.70M | |||
| Total Non-Current Assets | 48.40M | 50.80M | 47.10M | 57.40M | 49.40M | |||
| TOTAL ASSETS | 202.30M | 218.90M | 322.40M | 280.90M | 399.30M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 9.40M | 9.40M | 800.00K | 4.90M | N/A | |||
| Accrued Expenses | 35.50M | 37.20M | 31.00M | 37.00M | 40.90M | |||
| Accounts Payable | 3.70M | 9.30M | 10.00M | 8.80M | 12.00M | |||
| Other Current Liabilities | 700.00K | 4.60M | 1.00M | 900.00K | 3.00M | |||
| Total Current Liabilities | 49.40M | 60.60M | 42.80M | 51.60M | 55.90M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 16.20M | 23.00M | 32.10M | 20.20M | 24.70M | |||
| Other Non-Current Liabilities | 56.50M | 37.10M | 37.60M | 30.70M | 19.50M | |||
| Total Non-Current Liabilities | 72.60M | 60.00M | 69.70M | 50.90M | 44.20M | |||
| TOTAL LIABILITIES | 122.00M | 120.60M | 112.50M | 102.50M | 100.10M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -965.90M | -900.90M | -750.20M | -605.60M | -453.70M | |||
| Additional Paid In Capital | 994.10M | 956.70M | 940.70M | 771.20M | 738.50M | |||
| Common Shares | 29.50M | 16.40M | 16.30M | 12.50M | 12.30M | |||
| Other Shareholders' Equity | 22.60M | 26.00M | 3.20M | 400.00K | 2.00M | |||
| Shares Outstanding | 22.65M | 12.65M | 12.53M | 9.80M | 9.66M | |||
| Tangible Book Value per Share | 0.34 | 0.75 | 1.63 | 1.81 | 3.09 | |||
| Total Shareholders' Equity | 80.30M | 98.30M | 210.00M | 178.40M | 299.20M | |||
| TOTAL LIABILITIES AND EQUITY | 202.30M | 218.90M | 322.40M | 280.90M | 399.30M | |||
| Statistics | ||||||||
| Debt/Equity | 0.20 | 0.23 | 0.15 | 0.11 | 0.08 | |||
| Current Ratio | 3.12 | 2.77 | 6.43 | 4.33 | 6.26 | |||
| Return On Assets (ROA) | -36.05% | -68.83% | -44.84% | -54.10% | -40.93% | |||
| Return On Equity (ROE) | -90.81% | -153.27% | -68.85% | -85.19% | -54.62% | |||
All data in USD